Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZV27P)

Drug Name

SXC-2023 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Trichotillomania	6B25.0	Phase 2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cystine/glutamate transporter (SLC7A11)	TTBZMIO	XCT_HUMAN	Activator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03797521) A Study in Patients With Trichotillomania (TTM). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Promentis Pharmaceuticals.